HK1 and prostate cancer: This indicates a pivotal role for these glycolytic enzymes in the supply of energy to drive the progression of breast and prostate cancers, as explained by the Warburg effect [22,23], which could be harnessed as a treatment strategy for both cancers [24,25,26].